Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
ONCY:NASDAQ
Oncolytics Biotech Inc
US$0.87
-1.12%
(-0.0099) 1D
US$0.88
+1.14% (+0.0099)
Pre-market
Closed: 1 મે, 04:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ONCY...
ખોલો
US$0.90
High
US$0.92
Low
US$0.87
Mkt. cap
૧૦.૧૦ કરોડ
Volume
૧.૬૭ હજાર
52-wk high
US$1.51
52-wk low
US$0.33
EPS
-US$0.30
Beta
૧.૦૨
Shares outstanding
૧૧.૬૧ કરોડ
No. of employees
૨૯
News stories
From sources across the web
પ્રોફાઇલ
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
Headquartersકેલગરી, આલ્બર્ટા, કેનેડા
Sector-
Websiteoncolyticsbiotech.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
ડિસે 2024
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
40.83 લાખ
28.09 લાખ
75.15 લાખ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
29.16 લાખ
28.97 લાખ
63.25 લાખ
Operating expense
-
69.99 લાખ
57.06 લાખ
1.38 કરોડ
Total operating expenses
-
69.99 લાખ
57.06 લાખ
1.38 કરોડ
Operating income
-
-69.99 લાખ
-57.06 લાખ
-1.38 કરોડ
Other non operating income
-
2.40 લાખ
-1.96 લાખ
-10.52 લાખ
EBT including unusual items
-
-66.87 લાખ
-60.80 લાખ
-1.47 કરોડ
EBT excluding unusual items
-
-66.87 લાખ
-60.80 લાખ
-1.47 કરોડ
Income tax expense
-
-
85.00 હજાર
-2.52 લાખ
Effective tax rate
-
-
-1.40%
1.72%
Other operating expenses
-
-
-
-
Net income
-
-66.87 લાખ
-61.65 લાખ
-1.44 કરોડ
Net profit margin
-
-
-
-
Earnings per share
-0.10
-0.08
-0.07
-0.14
Interest and investment income
-
1.23 લાખ
1.04 લાખ
1.00 લાખ
Interest expense
-
-
-
-
Net interest expenses
-
1.23 લાખ
1.04 લાખ
1.00 લાખ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-69.73 લાખ
-56.81 લાખ
-1.38 કરોડ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer